Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 14, 2020
Comparison of Myeloablative (CyTBI, BuCy) versus Reduced-Intensity (FluBu2TBI400) Peripheral Blood Stem Cell Transplantation in Acute Myeloid Leukemia Patients with Pretransplant Low WT1 ExpressionSilvia Park, Gi June Min, Sung Soo Park, et al.
Therapeutic Advances in Hematology|September 30, 2021
Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndromeSilvia Park, Tong Yoon Kim, Jong Hyuk Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2014
A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemiaSeung-Ah Yahng, Jung-Ho Kim, Young-Woo Jeon, et al.
Acta Haematologica|November 22, 2014
Equivalent outcome of autologous stem cell transplantation and reduced intensity conditioning stem cell transplantation in acute myeloid leukemia patients with t(8;21)Ki-Seong Eom, Hee-Je Kim, Byung-Sik Cho, et al.
European Journal of Haematology|November 2, 2012
Response to pretransplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromesSeung-Ah Yahng, Jae-Ho Yoon, Seung-Hwan Shin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndromeSeung-Hwan Shin, Jung-Ho Kim, Young-Woo Jeon, et al.
European Journal of Haematology|February 18, 2014
Similar outcomes of peripheral blood stem cells vs. bone marrow for human leukocyte antigen-matched unrelated donor transplantation in adult patients with acute myeloid leukemia using risk-adapted graft-versus-host disease prophylaxisSeung-Hwan Shin, Jung-Ho Kim, Young-Woo Jeon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2019
WT1 Measurable Residual Disease Assay in Patients With Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation: Optimal Time Points, Thresholds, and CandidatesByung-Sik Cho, Gi-June Min, Sung-Su Park, et al.
Journal of Korean Medical Science|August 11, 2020
Epidemiological Characteristics of COVID-19 Outbreak at Fitness Centers in Cheonan, KoreaSanghyuk Bae, Hwami Kim, Tae Young Jung, et al.
Bone Marrow Transplantation|June 29, 2021
Prognostic values of D816V KIT mutation and peri-transplant CBFB-MYH11 MRD monitoring on acute myeloid leukemia with CBFB-MYH11Byung-Sik Cho, Gi-June Min, Sung-Soo Park, et al.
Pageof 11